Development and analytic validation of a radioimmunoassay for the quantification of canine calprotectin in serum and feces from dogs

American Journal of Veterinary Research

Volumn 69, Issue 7, 2008, Pages 845-853

  Heilmann, Romy M ^a,b   Suchodolski, Jan S ^a   Steiner, Jörg M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Veterinary Referral Center TÜZ   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG; ENTERITIS; FECES LEVEL; LINEAR SYSTEM; NONHUMAN; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY ANALYSIS; VALIDATION STUDY;

ANIMALS; DOG DISEASES; DOGS; FECES; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

CANIS FAMILIARIS;

EID: 48049123053     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.7.845     Document Type: Article

References (31)

1. Jergens AE. Clinical assessment of disease activity for canine inflammatory bowel disease. J Am Anim Hosp Assoc 2004;40:437-445.
2. Jergens AE, Moore FM, Haynes JS, et al. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). J Am Vet Med Assoc 1992;201:1603-1608.
3. Allenspach K, Wieland B, Gröne A, et al. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007;21:700-708.
4. Jergens AE, Schreiner CA, Frank DE, et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003;17:291-297.
5. McCann TM, Ridyard AE, Else RW, et al. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease. J Small Anim Pract 2007;48:620-625.
6. Johne B, Fagerhol MK, Lyberg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113-123.
7. Stříž I, Trebichavský I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004;53:245-253.
8. Sander J, Fagerhol MK, Bakken JS. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984;44:357-362.
9. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leukocyte derived protein (L1). Scand J Haematol 1980;24:393-398.
10. (2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 1995;56:406-414.
11. Røseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-798.
12. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506-513.
13. Røseth AG, Kristinsson J, Fagerhol MK, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993;28:1073-1076.
14. Fagerhol MK. Calprotectin, a faecal marker of organic gastro-intestinal abnormality. Lancet 2000;356:1783-1784.
15. Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
16. Røseth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2004; 39:1017-1020.
17. 131iodine-labeled human growth hormone of high specific activity. Nature 1962; 194:495-496.
18. Chiang CS. A linear method for determining specific activity of tracers in radioimmunoassays. Clin Chem 1987;33:1245-1247.
19. Ballard P, Stafford LE, Law B. The development and performance of a radioimmunoassay for the analysis of ZM 213,689, the major metabolite of meropenem - a carbapenem antibiotic - in plasma and urine. J Pharm Biomed Anal 1996;14:409-417.
20. Vaitukaitis J, Robbins J, Nieschlag E, et al. A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab 1971;33:988-991.
21. Berson SA, Yalow RS. General principles of radioimmunoassay. Clin Chim Acta 1968;22:51-69.
22. Midgley AR, Niswender GD, Rebar RW. Principles for the assessment of the reliability of radioimmunoassay methods (precision, accuracy, sensitivity, specificity). Acta Endocrinol Suppl (Copenh) 1969;142:163-184.
23. Skelley DS, Brown LP, Besch PK. Radioimmunoassay. Clin Chem 1973;19:146-186.
24. Fagerhol MK, Andersson KB, Naess-Andresen CF, et al. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, eds. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton, Fla: CRC Press, 1990;187-210.
25. Hyllner M, Arnestad JP, Bengtson JP, et al. Complement activation during storage of whole blood, red cells, plasma, and buffy coat. Transfusion 1997;37:264-268.
26. Hetland G, Talgö GJ, Fagerhol MK. Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. Mol Pathol 1998;51:143-148.
27. Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983;134:1-6.
28. Ensemble Genome Browser Web site. Canis familiaris (CanFam 2.0). Available at: www.ensembl.org/Canis_familiaris/index. html. Accessed Mar 10, 2007.
29. Arndt H, Kubes P, Grisham MB, et al. Granulocyte turnover in the feline intestine. Inflammation 1992;16:549-559.
30. John BJ, Abulafi AM, Poullis A, et al. Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people. Gut 2007;56:1034-1035.
31. Herder C, Schneider S, Rathmann W, et al. Low-grade inflammation, obesity and insulin resistance in adolescents. J Clin Endocrinol Metab 2007;92:4569-4574.